Author

Calena J. Brown

The University of Texas MD Anderson Cancer Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Ali Rizvi· 1 shared Constantin Zod· 1 shared Janak Abraham· 1 shared Jun‐ichi AbeiD· 1 shared Kaifu CheniD· 1 shared Lauren Reed· 1 shared Min Gyu LeeiD· 1 shared Shilpa S. DhariD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ali Rizvi

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCell ReportsPeer-reviewedApr 24, 2025

Heterozygous Kmt2d loss diminishes enhancers to render medulloblastoma cells vulnerable to combinatory inhibition of lysine demethylation and oxidative phosphorylation

Shilpa S. Dhar, Calena J. Brown, Ali Rizvi…·Min Gyu Lee

This study shows that heterozygous Kmt2d loss promotes medulloblastoma by enhancing tumor-promoting programs and that combining LSD1 inhibition with oxidative phosphorylation blockade reduces tumorigenicity.

8 citations

mouseChIP-seq

𝕏 PostBluesky